Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Pozycja w akcjach #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Cena akcji
$25.61
Ostatnia synchronizacja: 2025-10-10
Kapitalizacja rynkowa
$1.37B
Zmiana (1 dzień)
0.20%
Zmiana (1 rok)
1.59%
Kraj
US
Handel Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Kategoria

Historia ceny akcji dla Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Najwyższa cena zamknięcia: $25.59 dnia 2025-10-01

Najniższa cena zamknięcia: $25.61 dnia 2021-05-01
Historia cen akcji firmy Harrow Health, Inc. 8.625% Senior Notes due 2026 od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -0.14%
2025 1.11%
2024 5.61%
2023 0.96%
2022 -11.16%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$60.84 70.81%
US
$52.07 69.60%
SE
$193.46 40.55%
FR
$0.72 -27.92%
HK
$62.45 0.64%
IT